Sec Form 4 Filing - Mansano Roy @ OKMIN RESOURCES, INC. - 2022-04-08

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Mansano Roy
2. Issuer Name and Ticker or Trading Symbol
OKMIN RESOURCES, INC. [ OKMN]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
5343 OSTROM AVE.
3. Date of Earliest Transaction (MM/DD/YY)
04/08/2022
(Street)
ENCINO, CA91316
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3,000,000 D
Common Stock 1,250,000 I By Roy Mansano MD APMC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
10% Convertible Loan $ 0.03 04/08/2022 J( 1 ) 04/08/2022 05/08/2025 Common Stock 64,167( 2 ) $ 0 $ 240,625 I By Roy Mansano MD AMPC
Warrants ( 3 ) 04/08/2022 J( 3 ) 21,389 ( 3 ) ( 3 ) Common Stock 21,389 $ 0 2,673,611 I By Roy Mansano MD AMPC
10% Convertible Loan $ 0.03 04/08/2022 J( 4 ) 11/17/2021 05/08/2025 Common Stock 103,334( 5 ) $ 0 $ 237,525 I By Roy Mansano MD APMC
Warrants ( 6 ) 04/08/2022 J( 6 ) 34,445 ( 6 ) ( 6 ) Common Stock 34,445 $ 0 2,639,166 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 05/08/2022 J( 1 ) 05/08/2022 05/08/2025 Common Stock 63,306( 7 ) $ 0 $ 239,424.17 I By Roy Mansano MD APMC
Warrants ( 3 ) 05/08/2022 J( 3 ) 21,102 ( 3 ) ( 3 ) Common Stock 21,102 $ 0 2,660,268 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 05/08/2022 J( 4 ) 11/17/2021 05/08/2025 Common Stock 153,333( 8 ) $ 0 $ 234,824.17 I By Roy Mansano MD APMC
Warrants ( 6 ) 05/08/2022 J( 6 ) 51,111 ( 6 ) ( 6 ) Common Stock 51,111 $ 0 2,609,157 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 06/08/2022 J( 1 ) 06/08/2022 05/08/2025 Common Stock 62,027( 9 ) $ 0 $ 236,685 I By Roy Mansano MD APMC
Warrants ( 3 ) 06/08/2022 J( 3 ) 20,676 ( 3 ) ( 3 ) Common Stock 20,676 $ 0 2,629,833 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 06/08/2022 J( 4 ) 11/17/2021 05/08/2025 Common Stock 134,667( 10 ) $ 0 $ 232,645 I By Roy Mansano MD APMC
Warrants ( 6 ) 06/08/2022 J( 6 ) 44,889 ( 6 ) ( 6 ) Common Stock 44,889 $ 0 2,584,944 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 07/08/2022 J( 1 ) 07/08/2022 05/08/2025 Common Stock 60,906( 11 ) $ 0 $ 234,472.17 I By Roy Mansano MD APMC
Warrants ( 3 ) 07/08/2022 J( 3 ) 20,302 ( 3 ) ( 3 ) Common Stock 20,302 $ 0 2,605,246 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 07/08/2022 J( 4 ) 11/17/2021 05/08/2025 Common Stock 237,500( 12 ) $ 0 $ 227,347.17 I By Roy Mansano MD APMC
Warrants ( 6 ) 07/08/2022 J( 6 ) 79,167 ( 6 ) ( 6 ) Common Stock 79,167 $ 0 2,526,079 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 08/08/2022 J( 1 ) 08/08/2022 05/08/2025 Common Stock 58,927( 13 ) $ 0 $ 229,114.96 I By Roy Mansano MD APMC
Warrants ( 3 ) 08/08/2022 J( 3 ) 19,643 ( 3 ) ( 3 ) Common Stock 19,643 $ 0 2,545,722 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 08/08/2022 J( 4 ) 11/17/2021 05/08/2025 Common Stock 116,667( 14 ) $ 0 $ 225,614.96 I By Roy Mansano MD APMC
Warrants ( 6 ) 08/08/2022 J( 6 ) 38,889 ( 6 ) ( 6 ) Common Stock 38,889 $ 0 2,506,833 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 09/08/2022 J( 1 ) 09/08/2021 05/08/2025 Common Stock 57,954( 15 ) $ 0 $ 227,353.59 I By Roy Mansano MD APMC
Warrants ( 3 ) 09/08/2022 J( 3 ) 19,318 ( 3 ) ( 3 ) Common Stock 19,318 $ 0 2,526,151 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 09/08/2022 J( 4 ) 11/17/2021 05/08/2025 Common Stock 83,333( 16 ) $ 0 $ 224,853.59 I By Roy Mansano MD APMC
Warrants ( 6 ) 09/08/2022 J( 6 ) 27,778 ( 6 ) ( 6 ) Common Stock 27,778 $ 0 2,498,373 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 10/08/2022 J( 1 ) 10/08/2022 05/08/2025 Common Stock 57,260( 17 ) $ 0 $ 226,571.38 I By Roy Mansano MD APMC
Warrants ( 3 ) 10/08/2022 J( 3 ) 19,087 ( 3 ) ( 3 ) Common Stock 19,087 $ 0 2,517,460 I By Roy Mansano MD APMC
10% Convertible Loan $ 0.03 10/08/2022 J( 4 ) 11/17/2021 05/08/2025 Common Stock 116,667( 18 ) $ 0 $ 223,071.38 I By Roy Mansano MD APMC
Warrants ( 6 ) 10/08/2022 J( 6 ) 38,889 ( 6 ) ( 6 ) Common Stock 38,889 $ 0 2,478,571 I By Roy Mansano MD APMC
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Mansano Roy
5343 OSTROM AVE.
ENCINO, CA91316
X
Signatures
/s/ Roy Mansano 01/06/2023
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Represents interest accrued on the 10% Convertible Loan (the "Loan") on this date. The outstanding principal and accrued interest on the Loan (the "Loan Amount") is convertible at any time into shares of Common Stock at a conversion price of $0.03 per share. For every three shares of Common Stock received upon conversion of the Loan Amount, the holder will also receive one Warrant to buy an additional share of Common Stock at an exercise price of $0.03 per share. The Warrants underlying the Loan Amount are also reported on this form.
( 2 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 8,020,834.
( 3 )These Warrants are not currently outstanding but may be issued upon conversion of the interest that was accrued on the Loan on this date. The Warrants will be exercisable immediately if and when issued and will have an exercise price of $0.03 per share and a three-year term.
( 4 )Represents a Loan payment on this date, which reduced the Loan Amount by the amount of the payment.
( 5 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,917,500.
( 6 )These Warrants were subject to issuance upon conversion of the Loan Amount that was paid on this date. The Warrants would have been exercisable immediately if and when issued and would have had an exercise price of $0.03 per share and a three-year term.
( 7 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,980,806.
( 8 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,827,473.
( 9 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,889,500.
( 10 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,754,833.
( 11 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,815,739.
( 12 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,578,239.
( 13 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,637,166.
( 14 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,520,499.
( 15 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,578,453.
( 16 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,495,120.
( 17 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,552,380.
( 18 )The total number of shares underlying the Loan Amount after this transaction (not including shares underlying Warrants) is 7,435,713.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.